About 1 400 reports

Global Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cancer
  • Pathology
  • United States
  • World
  • Forecast

Global Market Study on Gastrointestinal Stromal Tumor: Stomach Indications to Account for Largest Revenue Share during 2017-2026 ##.

  • Cancer
  • Healthcare
  • World
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • France
  • United States
  • Market Shares

Europe Gastrointestinal Stromal Tumor Epidemiology and Patient Flow Analysis - 2017 ##.

  • Cancer
  • Europe
  • France
  • Germany
  • Italy

Gastrointestinal Stromal Tumor (GIST) - Epidemiology Forecast to 2027 ##.

  • Cancer
  • France
  • Germany
  • Italy
  • Spain

Drug A: Company ## ##. ##. ##.

  • Cancer
  • United States
  • Market Shares
  • 6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
  • GLOBAL - GASTROINTESTINAL CANCER LIQUID BIOPSY MARKET (MILLION US$), 2015 - 2017

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Cancer
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • 7.2 GASTROINTESTINAL TUMOR MODELS
  • GASTROINTESTINAL TUMOR MODELS IS EXPECTED TO ACCOUNT FOR THE

PDX models market is projected to grow at a CAGR of 16.7% The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer...

  • Cancer
  • United States
  • Charles River Laboratories International, Inc.
  • Horizon Discovery
  • WuXi AppTec Co.

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • France
  • Germany
  • Italy
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • United States
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Japan
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Italy
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • France
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Germany
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • United Kingdom
  • Market Shares

Gastrointestinal Stromal Tumors Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Pathology
  • Spain
  • Market Shares

" Target Atlas in Gastrointestinal Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, integrated with drug pipeline information covering commercial developments of molecular drug targets in gastrointestinal cancer from companie

  • Cancer
  • GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
  • BRAIN CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)

Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances,...

  • Cancer
  • World
  • Market Size
  • Accuray Incorporated
  • Elekta Group
  • SAFETY PROFILE OF HALAVEN IN THE THIRD-LINE TREATMENT OF METASTATIC BREAST CANCER
  • SAFETY OF ABRAXANE MONOTHERAPY IN THE TREATMENT OF METASTATIC BREAST CANCER

ipage=##& xml=##& quest=##& rid=##& section=##& sequence=-##& pdf=##& dn=## [Accessed February ##, 2017].

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

Of these, the majority of operations are in the area of obstetrics and gynecology, digestive/ gastrointestinal tract CONCLUSIONS Conclusion ## Chapter One: Executive Summary ## procedures, and orthopedics.

  • Cancer
  • Health Services
  • Hospital
  • World
  • Forecast
  • VERISANTE CORE - GASTROINTESTINAL CANCER
  • VERISANTE CORE - GASTROINTESTINAL CANCER - PRODUCT STATUS

Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for...

  • Cancer
  • Skin Cancer
  • Canada
  • GlobalData's company
  • Verisante Technology, Inc.
  • GASTROINTESTINAL STOOL TESTING MARKET IN APAC ($ MILLIONS)
  • GASTROINTESTINAL STOOL TESTING MARKET IN EMEA ($ MILLIONS)

About GI stool testing Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption...

  • Cancer
  • In Vitro Diagnostics
  • World
  • DiaSorin S.p.A.
  • Quidel Corporation

You can easily book an appointment with one online.

  • Cancer
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation
  • Cancer involving bone marrow

About Cancer Supportive Care Cancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others. Various class of drugs are used as cancer supportive care drugs. Some of the major drug class that involves...

  • Blood Disease
  • Cancer
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.

Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022 Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Methodology Geographic Breakdown Analyst’s Credentials Related BCC Research Reports Chapter ## Summary and Highlights Market Con

  • Cancer
  • Ovarian Cancer
  • Therapy
  • World
  • Market Size
  • Global Proton Therapy Cancer Indication Mix* (2016)
  • Global Cancer Indication Mix* (2016)

Within one year, their radiation completely decays.

  • Cancer
  • World
  • Hitachi, Ltd.
  • Ion Beam Applications S.A.
  • Varian Medical Systems, Inc.
  • PRODUCT DESCRIPTION

SYSTEMIC TETRACYCLINE MAY CAUSE GASTROINTESTINAL UPSET, NAUSEA, DIARRHEA, AND VAGINAL YEAST INFECTION.

  • Cancer
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.

IMRT has also been used in limited situations to treat breast, thyroid, lung, as well as in gastrointestinal, gynecologic malignancies and certain types of sarcomas.

  • Cancer
  • Forecast
  • Market Size
  • Hitachi, Ltd.
  • Mitsubishi Corporation
  • Global colonoscopy devices market segmentation by geography: Growth lifecycle analysis
  • COLONOSCOPY DEVICES MARKET IN AMERICAS

You can easily book an appointment with one online.

  • Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation
  • 6.1.5.2 IMATINIB(GLEEVEC)
  • Acute Myeloid Leukemia Therapeutics Market: Revenue in USD million, Tyrosine Kinase Inhibitors, Imatinib, Global, 2015-2023

TABLE OF CONTENTS ##.

  • Cancer
  • Celgene Corporation
  • Eisai Co., Ltd.
  • Genmab group
  • Novartis AG